Graypoint LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $225K | Buy |
|
|||||
|
2024
Q4 | $250K | Buy |
|
|||||
|
2024
Q3 | $271K | Buy |
|
|||||
|
2024
Q2 | $240K | Buy |
|
|||||
|
2024
Q1 | $244K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $299K | Buy |
|
|||||
|
2023
Q1 | $263K | Buy |
|
|||||
|
2022
Q4 | $267K | Buy |
|
|||||
|
2022
Q3 | $249K | Buy |
|
|||||
|
2022
Q2 | $229K | Sell |
|
|||||
|
2022
Q1 | $286K | Buy |
|